FEVARIN

This brand name is authorized in Germany, Estonia, Croatia, Italy, Lithuania, Netherlands, Poland, Romania

Active ingredients

The drug FEVARIN contains one active pharmaceutical ingredient (API):

1 Fluvoxamine UNII 5LGN83G74V - FLUVOXAMINE MALEATE

The mechanism of action of fluvoxamine is thought to be related to selective serotonin re-uptake inhibition in brain neurones. There is minimum interference with noradrenergic processes. Receptor binding studies have demonstrated that fluvoxamine has negligible binding capacity to alpha adrenergic, beta adrenergic, histaminergic, muscarine cholinergic, dopaminergic or serotonergic receptors. Read about Fluvoxamine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AB08	Fluvoxamine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 02796575, 02796581, 02796598, 03655049, 03655055, 07669634
Country: EE	Ravimiamet	Identifier(s): 1039564, 1070569, 1070570, 1115503, 1149791, 1149803
Country: IT	Agenzia del Farmaco	Identifier(s): 027045032, 027045044
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1000762, 1000763, 1000764, 1086868, 1087896, 1090872, 1091526
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 42013, 42021
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100024196, 100024204, 100436510, 100436527, 100453071
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68887001, W68888001